Drug Profile
GPX 325
Latest Information Update: 20 Jul 2007
Price :
$50
*
At a glance
- Originator BioResearch Ireland
- Class Radioprotectives
- Mechanism of Action Monoamine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chemotherapy-induced damage; Radiation injuries
Most Recent Events
- 10 Jun 1998 Preclinical development for Chemotherapy induced damage (Prevention)/Chemoprotection in Ireland (unspecified route)
- 10 Jun 1998 Preclinical development for Radiation injuries (Prevention)/Radioprotection in Ireland (unspecified route)